Stockreport

PAVmed Third Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF US$0.16 loss per share (improved from US$0.29 loss in 3Q 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period PAVmed Revenues Beat [Read more]